^

Health

Inspiron

, medical expert
Last reviewed: 23.04.2024
Fact-checked
х

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Inspiron demonstrates anti-inflammatory and anti-bronchoconstrictor activity.

Indications Inspirona

It is used for such violations:

  • having chronic or acute inflammation affecting the ENT organs and respiratory ducts (bronchitis with rhinotracheobronchitis, sinusitis, rhinitis with otitis, and at the same time rhinopharyngitis and tracheitis);
  • chronic obstructive pulmonary diseases;
  • combined asthma treatment;
  • runny nose allergic genesis of any type and other symptoms of intolerance associated with the ENT organs and the respiratory system;
  • elimination of pertussis;
  • respiratory flu or measles.

trusted-source

Release form

The release of the drug is made in pill form, 10 pieces inside the cellular packaging. In the box - 3 such packages.

Also sold as a syrup, in bottles with a capacity of 0.15 l; in the package - 1 bottle.

Pharmacodynamics

Therapeutic effect of Inspiron develops due to such mechanisms of action:

  • slowing down the activity of histamine H1-terminations, as well as relaxation of smooth muscles of the bronchi;
  • anti-inflammatory effect, contributing to the weakening of the binding of some anti-inflammatory elements (cytokines and TNF-a, and in addition leukotrienes with free radicals, thromboxane, metabolic products of arachidonic acid and PG), which have bronchoconstrictor properties;
  • inhibition of α1-adrenoreceptor activity, stimulating the production of viscous bronchial mucus.

trusted-source[1]

Pharmacokinetics

Blood Cmax values are recorded after 6 hours from the moment of taking the medicine.

Half-life is 12 hours. Excretion of the substance mainly occurs with the urine.

trusted-source[2], [3], [4]

Dosing and administration

Use the medication should be inside, after taking the food.

Schemes of use of the tablet form of medicine.

In chronic forms of violations, you need to use 1-well pill of drugs 2 times a day. To potentiate the effect of the drug, or in acute forms of disorders, it is necessary 3 times a day to apply 3 tablets of the substance. The duration of therapy is determined by the nature of the disease and is chosen personally by the attending doctor.

The regimen of the drug in the form of syrup.

Children older than 2 years of age are required to apply the drug in a serving of 2 ml / kg, which is divided into 2-3 uses. If the weight of the child is less than 10 kg, you should take 20-40 mg of medication per day (divided into 2-3 uses). If the weight is more than 10 kg, you need to consume 60-120 mg of a substance per day (also a division into 2-3 applications).

Daily dosage for adolescents older than 12 years and adults - 90-180 mg of drugs per day (division into 2-3 injections). The duration of the therapeutic cycle is chosen by the doctor personally, taking into account the nature of the pathology.

In the 1st teaspoon - 5 ml of medicinal syrup; in the 1st tablespoon, respectively - 15 ml of the substance.

trusted-source[7], [8]

Use Inspirona during pregnancy

You can not appoint Inspiron when breastfeeding or pregnancy.

Contraindications

It is contraindicated to use in case of strong intolerance associated with elements of drugs.

trusted-source[5]

Side effects Inspirona

Acceptance of a drug may cause some side effects:

  • digestive disorders: diarrhea, nausea, stomach pain, disorders of the digestive processes and vomiting;
  • problems with circulatory function: sinus tachycardia, disappearing after adjusting the portion;
  • lesions of the epidermis: rash, urticaria, erythema (also pigmented in nature), angioedema and itching;
  • symptoms on the part of NA: drowsiness;
  • systemic signs: feeling of fatigue or weakness.

trusted-source[6],

Overdose

The use of Inspiron in large portions can cause vomiting, a feeling of excitement or drowsiness, sinus tachycardia and nausea.

Gastric lavage, ECG procedure, and in addition to this symptomatic measures.

trusted-source[9],

Interactions with other drugs

Combining the medication with sedatives or drugs containing alcohol is prohibited, because this can cause the sedative effect of the blockers of the H1 endings to be stimulated.

trusted-source[10], [11], [12], [13]

Storage conditions

Inspiron is required to be kept in a place closed to the penetration of small children. Temperature marks - maximum 25 ° C.

Shelf life

Inspiron can be used within a 24-month period from the time a pharmaceutical product is released.

Application for children

In pediatrics, the drug is used exclusively in the form of a syrup. In this case, the syrup is prohibited to appoint children under the age of 2 years.

Analogs

Analogues of drugs are drugs Erespal, Fosidal and Bronhomax with Amispiron IC.

trusted-source[14]

Reviews

Inspiron is considered to be a fairly effective drug, but at the same time, reviews often mention the appearance of allergic symptoms associated with its use. In addition, there are reports that the medicine has an unpleasant smell and taste.

Attention!

To simplify the perception of information, this instruction for use of the drug "Inspiron" translated and presented in a special form on the basis of the official instructions for medical use of the drug. Before use read the annotation that came directly to medicines.

Description provided for informational purposes and is not a guide to self-healing. The need for this drug, the purpose of the treatment regimen, methods and dose of the drug is determined solely by the attending physician. Self-medication is dangerous for your health.

Translation Disclaimer: For the convenience of users of the iLive portal this article has been translated into the current language, but has not yet been verified by a native speaker who has the necessary qualifications for this. In this regard, we warn you that the translation of this article may be incorrect, may contain lexical, syntactic and grammatical errors.

You are reporting a typo in the following text:
Simply click the "Send typo report" button to complete the report. You can also include a comment.